Difference between revisions of "Muthusamy BP, et al. PLoS Biol. (2015) cited as Ref 349 in DOI: 10.1038/s41392-020-0110-5 (Q9612)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2015, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Page(s) (P105): e1002325-, #quickstatements; #temporary_batch_1590074839150) |
||
(3 intermediate revisions by the same user not shown) | |||
Property / Published In Name String | |||
+ | PLoS Biol. | ||
Property / Published In Name String: PLoS Biol. / rank | |||
+ | Normal rank | ||
Property / Volume | |||
+ | 13 | ||
Property / Volume: 13 / rank | |||
+ | Normal rank | ||
Property / title | |||
+ | ShcA protects against epithelial-mesenchymal transition through compartmentalized inhibition of TGF-beta-induced Smad activation (English) | ||
Property / title: ShcA protects against epithelial-mesenchymal transition through compartmentalized inhibition of TGF-beta-induced Smad activation (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | e1002325- | ||
Property / Page(s): e1002325- / rank | |||
+ | Normal rank |
Latest revision as of 15:38, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Muthusamy BP, et al. PLoS Biol. (2015) cited as Ref 349 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Muthusamy BP
0 references
2015
0 references
PLoS Biol.
0 references
13
0 references
ShcA protects against epithelial-mesenchymal transition through compartmentalized inhibition of TGF-beta-induced Smad activation (English)
0 references
e1002325-
0 references